Tyrosine-kinase inhibitors in the treatment of non-small cell lung cancer in usual clinical practice

被引：0
|
作者：
Caparros Romero, S. [1 ]
Ruiz Fuentes, S. [1 ]
机构：
[1] Hosp Axarquia, Pharm, Malaga, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2022年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PP176
引用
收藏
页码：1553 / 1553
页数：1
相关论文
共 50 条
  • [41] In vitro PK/PD modeling of tyrosine kinase inhibitors in non-small cell lung cancer cell lines
    Wanika, Linda
    Evans, Neil D.
    Johnson, Martin
    Tomkinson, Helen
    Chappell, Michael J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [42] Failure to Tyrosine Kinase Inhibitors and Patterns of Progression in Patients with Advanced Non-Small Cell Lung Cancer
    Barron, Feliciano
    Ramirez-Tirado, Laura-Alejandra
    Caballe-Perez, Enrique
    Sanchez, Gisela
    Cardona, Andres
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1269 - S1270
  • [43] Identification of novel mechanisms of resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
    de Bruin, Elza C.
    Cowell, Catherine F.
    Howell, Michael
    Varmus, Harold E.
    Politi, Katerina
    Downward, Julian
    CANCER RESEARCH, 2011, 71
  • [44] A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC)
    Byun, Joo-Young
    Park, Sun-Kyeong
    Ng, Boon Peng
    Liu, Yi-Shao
    Kim, Chae-Rin
    Park, Chanhyun
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (11) : 1247 - 1257
  • [45] Ferritinophagy mediates adaptive resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
    Wang, Hui
    Hu, Qianfan
    Chen, Yuzhong
    Huang, Xing
    Feng, Yipeng
    Shi, Yuanjian
    Li, Rutao
    Yin, Xuewen
    Song, Xuming
    Liang, Yingkuan
    Zhang, Te
    Xu, Lin
    Dong, Gaochao
    Jiang, Feng
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [46] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer
    Malik, Prabhat Singh
    Jain, Deepali
    Kumar, Lalit
    ONCOLOGY, 2016, 91 : 26 - 34
  • [47] Epidermal growth factor receptor tyrosine kinase inhibitors - Application in non-small cell lung cancer
    Thomas, M
    CANCER NURSING, 2003, 26 (06) : 21S - 25S
  • [48] Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
    Hammerman, Peter S.
    Jaenne, Pasi A.
    Johnson, Bruce E.
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7502 - 7509
  • [49] Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer
    Thompson, Jonathan R.
    Menon, Smitha P.
    Dy, Grace K.
    ADMET AND DMPK, 2016, 4 (03): : 186 - 211
  • [50] Elucidating mechanisms of resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC)
    Pao, William
    Miller, Vincent A.
    Kris, Mark G.
    Varmus, Harold E.
    ANNALS OF ONCOLOGY, 2004, 15 : 4 - 4
12345